Literature DB >> 8760013

Expression of cytokeratin messenger RNA versus protein in the normal mammary gland and in breast cancer.

L Su1, P R Morgan, E B Lane.   

Abstract

It is not known how tightly regulation of cytokeratin (CK) protein expression is correlated with transcriptional activity in breast cancer. The level of control of CK expression in the normal mammary gland and in breast cancer has been assessed by combining in situ hybridization with riboprobes, and with immunohistochemistry using monospecific antibodies. In normal mammary gland, luminal cells showed abundant hybridization with complementary RNA (cRNA) probes for CK7, CK8, CK18, and CK19. Proteins of these CKs were correspondingly distributed except for that of CK19, which showed a heterogeneous staining. In primary carcinomas, both messenger RNAs (mRNAs) and proteins of CK8 and CK18 were generally expressed to a degree similar to that of normal epithelia, but a lower level of mRNA and protein of CK18 was observed in metastatic carcinomas. Reduced expression of CK7 and CK14 was observed in all carcinomas, and the correlation between mRNA and protein for these two cytokeratins was unbalanced, whereas the expression of CK19 mRNA and the proportion of its protein-positive cells were increased. The results suggest that these major CKs in normal mammary gland epithelia are regulated at the transcriptional level except for CK19, which is partially under the posttranscriptional control. The alterations observed in breast cancer are not only reflected by the reduced or increased expression of individual cytokeratins, but characterized by partial loss of the normal regulation of cytokeratin expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760013     DOI: 10.1016/s0046-8177(96)90452-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

1.  Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.

Authors:  M J Page; B Amess; R R Townsend; R Parekh; A Herath; L Brusten; M J Zvelebil; R C Stein; M D Waterfield; S C Davies; M J O'Hare
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Immunohistochemical expression of myoepithelial markers in adenomyoepithelioma of the breast: a unique paradoxical staining pattern of high-molecular weight cytokeratins.

Authors:  Suzuko Moritani; Shu Ichihara; Yasushi Yatabe; Masaki Hasegawa; Akari Iwakoshi; Waki Hosoda; Michihiko Narita; Yuichiro Nagai; Masami Asai; Nobuko Ujihira; Yoshiaki Yuba; Mayumi Jijiwa
Journal:  Virchows Arch       Date:  2014-12-06       Impact factor: 4.064

3.  Molecular characterisation of breast cancer patients at high and low recurrence risk.

Authors:  Serena Bonin; Davide Brunetti; Elena Benedetti; Isabella Dotti; Nader Gorji; Giorgio Stanta
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

4.  ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation.

Authors:  Zheqi Li; Olivia McGinn; Yang Wu; Amir Bahreini; Nolan M Priedigkeit; Kai Ding; Sayali Onkar; Caleb Lampenfeld; Carol A Sartorius; Lori Miller; Margaret Rosenzweig; Ofir Cohen; Nikhil Wagle; Jennifer K Richer; William J Muller; Laki Buluwela; Simak Ali; Tullia C Bruno; Dario A A Vignali; Yusi Fang; Li Zhu; George C Tseng; Jason Gertz; Jennifer M Atkinson; Adrian V Lee; Steffi Oesterreich
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 17.694

Review 5.  Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer.

Authors:  Barry A Gusterson; Douglas T Ross; Victoria J Heath; Torsten Stein
Journal:  Breast Cancer Res       Date:  2005-05-05       Impact factor: 6.466

6.  HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes.

Authors:  Baki Akgül; Lucy Ghali; Derek Davies; Herbert Pfister; Irene M Leigh; Alan Storey
Journal:  Exp Dermatol       Date:  2007-07       Impact factor: 3.960

7.  Spontaneous Mammary Adenocarcinoma in a Twelve-week-old Female Sprague-Dawley Rat.

Authors:  Kazuya Kuzutani; Toshiyuki Shibanushi; Yumi Kangawa; Tohru Kihara
Journal:  J Toxicol Pathol       Date:  2012-10-01       Impact factor: 1.628

8.  ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in Metastases.

Authors:  Kristiina Joensuu; Marjut Leidenius; Mia Kero; Leif C Andersson; Kathryn B Horwitz; Päivi Heikkilä
Journal:  Breast Cancer (Auckl)       Date:  2013-02-13

9.  Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.

Authors:  Valérie Choesmel; Jean-Yves Pierga; Claude Nos; Anne Vincent-Salomon; Brigitte Sigal-Zafrani; Jean-Paul Thiery; Nathalie Blin
Journal:  Breast Cancer Res       Date:  2004-07-29       Impact factor: 6.466

10.  Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR.

Authors:  Jiatao Lou; Suqin Ben; Guohua Yang; Xiaohui Liang; Xiaoqian Wang; Songshi Ni; Baohui Han
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.